Mastering the Complex Targeted Therapy for Non-small Cell Lung Cancer.

Abstract excerpt

In a recent Nature article, Middleton et al. report the National Lung Matrix trial results where patients with previously treated non-small cell lung cancer (NSCLC) are assigned to personalized therapy based on the results of a 28-gene next-generation sequencing panel test.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Carcinoma, Non-Small-Cell Lung
• Share to High-Throughput Nucleotide Sequencing
• Share to Lung